apl. Prof. Dr. Peter Goebell

Medizinische Fakultät Urologische Klinik

Effect of Recipient Variables on Transplant Survival Following Marginal Kidney Donation: Analysis of a Mate Kidney Cohort (2025) Androvitsanea A, Heller KM, Apel H, Kunath F, Goebell P, Wullich B, Rother U, et al. Journal article Results of the Prospective Randomized UroFollow Trial Comparing Marker-guided Versus Cystoscopy-based Surveillance in Patients with Low/Intermediate-risk Bladder Cancer (2025) Schmitz-Dräger B, Bismarck E, Roghmann F, von Landenberg N, Noldus J, Jahn D, Kernig K, et al. Journal article Improving quality of care for cancer patients through oncological second opinions in a Comprehensive Cancer Center: adherence to second-opinion therapy recommendations (2025) Schulmeyer C, Fasching P, Beckmann M, Häberle L, Golcher H, Goebell P, Pöschke P, Emons J Journal article Change of the guards—Looking back at Michael Droller: Visionary and supporter—The perspective of the International Bladder Cancer Network (2025) Schmitz-Dräger B, Grossmann HB, Goebell P, Kamat AM, Black PC Journal article Head-to-head comparison of TKI and CPI first-line treatment strategies in advanced renal cell carcinoma—Real-world data from the German research platform CARAT (2025) Goebell P, Bögemann M, Nusch A, Grünwald V, Müller L, von der Heyde E, Martens UM, et al. Journal article Androgenrezeptor-gerichtete Therapien – klinisch relevante Interaktionen vermeiden (2025) Lipp HP, Von Amsberg G, Merseburger AS, Rausch S, Schöning T, Klier J, Goebell P Journal article, Review article Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial (2025) Bergmann L, Albiges L, Ahrens M, Gross-Goupil M, Boleti E, Gravis G, Fléchon A, et al. Journal article PSA im Extrembereich – Ausdruck einer infausten Prognose? Eine Übersicht über Verlauf und Therapie des Prostatakarzinoms mit PSA-Werten (prostataspezifisches Antigen) im drei- bis vierstelligen Bereich (2025) Dirscherl C, Ebert T, Schmitz-Dräger BJ, Goebell P Journal article Correction to: Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis (Current Oncology Reports, (2024), 26, 12, (1639-1650), 10.1007/s11912-024-01613-7) (2025) Frazer R, Arranz JÁ, Estévez SV, Parikh O, Krabbe LM, Vasudev NS, Doehn C, et al. Journal article, Erratum Cardiovascular Safety of GnRH Agonist-Based Androgen Deprivation Therapy in a Real-World Setting: Results from a Prospective Cohort Study (LEAN) (2025) Schmitz-Dräger BJ, Bismarck E, Ebert T, Starlinger R, Dienes K, Ottillinger B, Goebell P, et al. Journal article